China has a very large weight management market. It does not have a very large market for products that say they make you lose weight. Those are two different things, and the gap between them is where most Western brands lose their money. Before you price a single SKU, you need to know which side of that line your product falls on.
The old version of this article talked about a “favorable regulatory environment”. That was never true and it is less true now. What follows is the actual rulebook in 2026, then the parts of the market that are genuinely open.
I am Olivier Verot, founder of Gentlemen Marketing Agency, based in Shanghai since 2012. I have run China launches for supplement, sports nutrition and functional food brands, including several that had to rebuild their entire claim structure after a platform pulled their listings.
The 2026 numbers you should be working from
The demand side is real and it is official policy. In June 2024 the National Health Commission and sixteen other departments launched the “Weight Management Year” (体重管理年), a three-year action plan that runs through 2026. Government figures behind it put adult overweight prevalence above 50% and adult obesity above 16%. A state health campaign telling 700 million adults to watch their weight is the best demand generator a nutrition brand could ask for. It also means the regulator is watching the category more closely, not less.
| What changed | 2026 status | What it means for you |
|---|---|---|
| Semaglutide patent in China | Core compound patent expired March 2026 | Prescription weight loss got cheap, fast |
| Novo Nordisk semaglutide 3ml, provincial procurement | Fell from about RMB 2,463 to about RMB 1,284 | Your supplement now competes with a drug at half price |
| Tirzepatide monthly cost, some doses | Down more than 80% | Price pressure across the whole category |
| GLP-1 penetration of the eligible population | Around 1% | Still 99% of demand outside the prescription channel |
| Blue Hat approvals, first 2026 batch | 35 domestic, 1 imported | Imported registration is possible but rare |
| Advertising enforcement, H1 2026 | 20,302 cases, RMB 105 million in fines | Claim compliance is not theoretical |
| SAMR online food false-claims campaign | Six months from 30 April 2026 | Livestream and e-commerce copy under review |
The claim is the product
Say “weight loss” and you become a different legal category
This is the single point most brands get wrong. In China, a product is classified by what it claims, not by what is in the bottle. The moment your label, listing or KOL script says the product helps you lose weight or reduce fat, it stops being an ordinary food. It becomes a 保健食品, a health food, and health foods require state registration.
That registration is the Blue Hat (蓝帽子), named after the blue logo you must print on the pack. “Weight loss” (减肥) is one of the officially listed health food functions, and it is one of the hardest to get. Registration for a claimed function requires animal studies and human trial data submitted to the authorities, plus a full dossier on formula, production and stability. Approved products carry a registration number: 国食健注G for domestic, 国食健注J for imported. You can check any competitor’s number in the public database, and you should, because a lot of brands on Tmall are quietly claiming things they never registered.
How hard is imported registration in practice? In the first batch of 2026 approvals reported by the trade press, 35 were domestic products and one was imported. Read that ratio again before you budget a Blue Hat file. Timelines for a functional claim commonly run two to three years and the cost sits in six figures USD once you include the trials. It is a real option for a brand with a long horizon. It is not a launch plan.
Cross-border avoids registration, and forbids the claim
The cross-border channel (Tmall Global, JD Worldwide, bonded warehouse) lets you sell an imported supplement without a Blue Hat, because the goods are legally treated as a personal import rather than a domestic retail product. No registration, no Chinese-language regulatory label, much faster to market. That is why almost every foreign supplement brand starts there.
The trade-off is absolute. Without registration you have no approved function, so you cannot make a weight loss claim anywhere: not on the detail page, not in a livestream, not in an influencer post you paid for. Brands forget that last one. The advertising law holds the advertiser responsible for what the host says on air, and the current enforcement campaign explicitly targets marketing agencies and livestreamers as well as sellers. I have seen a European brand get its whole Douyin store frozen because one host improvised a line about “burning fat” that was nowhere in the approved script.
Enforcement is active, not dormant
On 30 April 2026 the State Administration for Market Regulation opened a six-month national campaign against false claims in online food and health food sales, covering five categories of actors: platforms, sellers on those platforms, marketing service agencies and their staff, advertising entities, and producers. The stated priorities include ordinary foods dressed up as having therapeutic effects, exaggerated health-food efficacy, and fake expert endorsements.
The scale is not symbolic. In the first half of 2026, market regulators handled 20,302 advertising violation cases with RMB 105 million in fines, with food, health food and medical products named as priority sectors. Slimming copy is a permanent feature of those case lists. Budget for legal review of your Chinese copy the same way you budget for photography.
GLP-1 changed the shape of the demand
The biggest shift since this article was first written has nothing to do with marketing. Semaglutide’s core compound patent in China expired in March 2026, and prices collapsed. Novo Nordisk’s 3ml injection went from roughly RMB 2,463 to roughly RMB 1,284 on provincial procurement platforms. Tirzepatide monthly costs dropped by more than 80% at some doses. Domestic players including Innovent are pushing their own molecules, and more than a dozen companies are lining up generics.
The consumer who used to buy an expensive imported “fat burner” out of hope now has a prescription option that works and no longer costs a fortune. That consumer is gone from your funnel. Do not try to win them back with claims, because you legally cannot, and because you would lose on evidence anyway.
Two things follow. First, GLP-1 still reaches only about 1% of the eligible population, so the volume outside the prescription channel remains enormous. Second, and more interesting commercially, GLP-1 users are themselves a nutrition market. Appetite suppression creates real protein and micronutrient gaps, and Chinese consumers on these drugs are actively searching for support products. Positioning as nutritional support alongside medical weight management is legitimate, defensible and largely uncontested by foreign brands right now.
Fitness membership growth is what makes sports nutrition sellable without a single slimming claim.
Where the legitimate money is: 体重管理
The accepted framing in China is 体重管理, weight management. It is the government’s own wording. It describes a behaviour, not a promised outcome, and it lets you talk to exactly the same consumer without triggering health food registration. Build your whole positioning on it.
Four segments work under that framing:
- Sports nutrition. Protein, amino acids, recovery. Chinese industry trackers put the protein powder category above RMB 38 billion in 2026 with growth near 18%, and the buyer profile has flipped: fitness-first buyers have fallen to under 40% of purchases while women buying for body shaping have become the largest group. This is the cleanest entry point for a foreign brand. See our guide to China’s sports nutrition market.
- Meal replacement. Shakes, bars, low-GI staples. Sold on calorie content and convenience, both of which are facts, not claims. The core buyer is 20 to 35, urban, female-skewed, and the category has spread from tier-1 into lower-tier cities.
- Functional foods for satiety. High fibre, high protein, resistant starch. You describe the composition and let the consumer draw the conclusion. Chinese labelling rules allow nutrient content statements without a health food licence.
- Nutrition support for medical weight management. The GLP-1 adjacency described above. New, growing, and thin on foreign competition.
Note what is not on that list: herbal slimming teas and traditional-remedy fat burners. The earlier version of this article recommended them. In the current enforcement climate, marketing a tea on the basis that it aids metabolism or reduces fat is a claim, and an unregistered one. Traditional ingredients are still a strong flavour and heritage story. They are not a permitted efficacy story.
Case study: Lena, a Polish sports nutrition brand
Lena runs a family-owned sports nutrition company in Poland. Whey isolate, plant protein, a fibre blend. Solid business in Central Europe, roughly EUR 9 million in annual revenue, and a distributor in Shanghai who had been sitting on the brand for two years without moving stock.
Her first attempt was a straight translation of her European positioning. The hero product was the fibre blend, sold in Poland as a slimming aid. On Tmall Global the detail page said so. Two listings were taken down within six weeks and the third was flagged. She had also bought a burst of KOL posts on Douyin using the same language, RMB 380,000 spent, most of the content pulled by the platform’s own review. Attributable sales for the quarter came to under RMB 60,000. She was about to write China off.
We changed the product hierarchy, not the products. The fibre blend went to the back. The whey isolate became the hero, sold on protein per serving, amino acid profile and Polish dairy origin, all verifiable facts that require no registration. Positioning moved from slimming to 体重管理 and post-workout recovery. Every piece of Chinese copy went through claim review before it went live, including a locked script for livestream hosts with a list of forbidden words.
The channel changed too. Instead of paid KOLs, we built roughly 120 KOC seeding placements on Xiaohongshu over four months, real users posting real routines, at a fraction of the previous cost. Xiaohongshu is where Chinese women research this category before they buy, and its in-app search behaves like a product search engine. We also started answering the questions Chinese AI assistants get asked about protein sourcing, so that DeepSeek and Doubao have accurate Polish-origin information about the brand to draw on. Buyers who converted went into a WeChat group run by a nutritionist, which is where repeat orders actually happen.
Why it worked: nothing in the new setup depended on a claim she was not allowed to make. Fourteen months in, Lena is at roughly RMB 4.1 million in annualised China revenue, repeat purchase around 34%, and zero listing takedowns. Slower than she wanted. Still there, which is the point.
Xiaohongshu search is where the weight management category gets researched. Optimise for it like a search engine, because that is what it is.
What still works from the old playbook
Consumer behaviour
Chinese consumers in this category want convenience and want to see something happen. They compare prices ruthlessly and they check ingredient lists. Preference for foreign origin is still there in supplements, though it has narrowed a lot as domestic brands improved.
Brand safety matters more here than in almost any other category, because the market has a long memory of scandals. Certifications, origin traceability and third-party testing are worth putting on the pack. Social proof drives the purchase: KOL and KOC content, reviews, user-generated posts. That has not changed since 2019 and will not change soon.
Product adaptation
Adaptation still pays, but adapt the right things:
- Portion sizes and single-serve packaging. Chinese urban buyers want to try before they commit to a tub.
- Flavour. Western sweetness levels are consistently too high. Matcha, taro, black sesame and osmanthus outperform vanilla.
- Format. Ready-to-drink and stick packs beat large containers for the office worker segment.
- Label transparency. Protein per 100g, sugar, fibre, clearly stated. Facts sell here precisely because claims are restricted.
Channel and distribution
Cross-border first, general trade later once volume justifies registration and a local entity. Tmall Global and JD Worldwide remain the default, though a lot of budget has moved to Douyin. Douyin’s interest-based commerce is well suited to meal replacement and RTD formats, where the product can be demonstrated in fifteen seconds. It is badly suited to anything needing explanation, and it is the channel where claim violations get caught fastest.
Build a private domain from day one. A WeChat service account plus community groups gives you a repeat-purchase base you own, and repeat purchase is the entire economics of nutrition. Acquisition on Douyin or Tmall is expensive; the second and third orders are where you make money. Our notes on health and pharma marketing practices in China cover the compliance side of running those communities.
Search, including the AI kind
Baidu still matters for the research phase and for B2B credibility, and Baidu SEO remains cheap relative to paid social. But two other search surfaces now matter as much. Xiaohongshu in-app search is where category research happens, so your brand needs indexed content answering the questions buyers type there. And Chinese AI assistants, DeepSeek and Doubao in particular, are increasingly the first stop for “which protein powder should I buy”. They answer from whatever Chinese-language content exists about you. If that is nothing, they will recommend your competitor. Publishing accurate, factual Chinese content about your formulation and sourcing is now a distribution decision, not a content decision.
Trust, evidence and credibility
Certifications and third-party testing reassure buyers and are the raw material for a future Blue Hat file if you ever go that route. Clinical data on a Chinese population is expensive but it is the only path to a registered functional claim, so treat it as a strategic investment rather than a marketing asset.
Partnerships with hospitals, fitness chains and registered dietitians build credibility fast. Be careful with the medical side: an endorsement that reads as a therapeutic claim is exactly what the current campaign is looking for. Our earlier piece on the vitamins and health supplements market in China covers the trust-building mechanics in more detail.
FAQ
Can I sell a weight loss supplement in China without a Blue Hat?
You can sell the product through cross-border e-commerce without registration. You cannot describe it as a weight loss product. Without a Blue Hat you have no approved function, so any slimming or fat-reduction wording on your listing, packaging, ads or influencer content is a violation. Sell it on composition and let the category positioning do the work. If you need the claim itself, you need the registration, and that means trials, two to three years, and a serious budget.
How likely is an imported product to get Blue Hat approval?
Possible, but rare. In the first batch of 2026 approvals reported by industry press, 35 went to domestic products and one to an imported product. Imported files carry extra requirements, including proof the product is legally sold in its home market and on-site inspection of the overseas plant. Most foreign brands that do get there start with cross-border, prove demand for two or three years, then commit to registration for one flagship SKU rather than a whole range.
Have GLP-1 drugs killed the supplement market?
They have killed one part of it. Consumers who wanted a pill that produces weight loss now have a prescription option that got roughly 50% cheaper in 2026 after the semaglutide patent expired. Products that were competing on that promise are in trouble. But GLP-1 reaches around 1% of the eligible population, and users of these drugs need protein and micronutrient support because appetite drops sharply. Sports nutrition, meal replacement and satiety foods are growing, not shrinking.
What actually gets a listing taken down?
Any efficacy language on an unregistered product. Before and after imagery. Numbers implying a result, such as kilos lost or days to a result. Claiming a food prevents or treats a condition. Fake or unqualified expert endorsement. Livestream hosts improvising off-script, which is the most common failure because brands review the written copy and forget the spoken word. Lock your scripts, brief every host in writing, and keep the recordings.
Working with GMA on weight management
GMA runs China launches for nutrition, supplement and functional food brands from Shanghai, and we start every one of them with a claim audit, because in this category the compliance question decides the marketing plan rather than the other way round. We handle cross-border store setup, Xiaohongshu and Douyin content, KOC seeding, WeChat private domain and Chinese-language search including the AI assistants. We do not promise weight loss results and we will not write copy that does.
If you want an honest read on whether your product can be sold in China as it stands, contact us and we will tell you what needs to change before you spend anything.
Olivier Verot, founder, Gentlemen Marketing Agency, Shanghai. LinkedIn. Further reading: selling dietetics products in China and market data from iiMedia Research on China’s sports nutrition market.
